HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylvie Négrier Selected Research

Antigens

12/2005Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylvie Négrier Research Topics

Disease

27Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 12/2002
14Neoplasms (Cancer)
06/2021 - 12/2005
4Kidney Neoplasms (Kidney Cancer)
01/2021 - 09/2008
4Neoplasm Metastasis (Metastasis)
01/2020 - 12/2002
4Disease Progression
11/2018 - 08/2008
3Melanoma (Melanoma, Malignant)
01/2020 - 12/2005
3Brain Neoplasms (Brain Tumor)
10/2019 - 02/2014
2Carcinoma (Carcinomatosis)
06/2021 - 09/2003
2Fatigue
06/2014 - 05/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2010 - 03/2003
1Papillary Carcinoma
06/2021
1Neurologic Manifestations (Neurological Manifestations)
11/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Pathologic Neovascularization
06/2014
1Diarrhea
05/2014
1Renal Insufficiency (Renal Failure)
01/2011
1Proteinuria
01/2011
1Hypertension (High Blood Pressure)
01/2011
1Thrombotic Microangiopathies
01/2011
1Adenocarcinoma
06/2010
1Tachycardia (Tachyarrhythmias)
11/2008
1Hypotension (Low Blood Pressure)
11/2008
1Neuroblastoma
10/2005
1Neutropenia
03/2003
1Febrile Neutropenia
03/2003
1Colorectal Neoplasms (Colorectal Cancer)
12/2002

Drug/Important Bio-Agent (IBA)

9Sunitinib (Sutent)FDA Link
01/2018 - 08/2008
8Bevacizumab (Avastin)FDA Link
01/2018 - 05/2010
6Tyrosine Kinase InhibitorsIBA
11/2018 - 01/2006
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018 - 07/2011
5Interferon-alpha (Interferon Alfa)IBA
01/2014 - 12/2002
4Biomarkers (Surrogate Marker)IBA
10/2021 - 10/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017 - 01/2011
4InterferonsIBA
06/2014 - 12/2002
4Interleukin-2 (IL2)IBA
11/2008 - 12/2002
3NivolumabIBA
01/2021 - 11/2018
3pazopanibFDA Link
08/2017 - 05/2014
3Irinotecan (Camptosar)FDA LinkGeneric
06/2010 - 03/2003
2Monoclonal AntibodiesIBA
08/2017 - 06/2014
2Pharmaceutical PreparationsIBA
02/2016 - 08/2008
2temsirolimusFDA Link
10/2015 - 07/2011
2Proteins (Proteins, Gene)FDA Link
01/2014 - 10/2005
2GemcitabineFDA Link
09/2003 - 03/2003
1Fumarate Hydratase (Fumarase)IBA
06/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1B7-H1 AntigenIBA
11/2018
1cabozantinibIBA
11/2018
1Axitinib (AG 013736)IBA
04/2018
1Hormones (Hormone)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1cadherin 5IBA
01/2018
1AlbuminsIBA
02/2016
1MTOR InhibitorsIBA
10/2015
1Dihydrotachysterol (AT 10)IBA
03/2015
1Vascular Endothelial Growth Factor CIBA
01/2014
1InterleukinsIBA
01/2014
1Sorafenib (BAY 43-9006)FDA Link
09/2011
1Radiation-Sensitizing AgentsIBA
06/2010
1Interferon alpha-2 (Roferon-A)FDA Link
05/2010
1shark cartilage extractIBA
11/2007
1AntigensIBA
12/2005
1Peptides (Polypeptides)IBA
12/2005
1VaccinesIBA
12/2005
1HLA-A1 Antigen (HLA A1 Antigen)IBA
12/2005
1Cisplatin (Platino)FDA LinkGeneric
09/2003
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2003
1Docetaxel (Taxotere)FDA Link
03/2003

Therapy/Procedure

12Therapeutics
10/2019 - 01/2006
4Radiotherapy
11/2018 - 06/2010
3Drug Therapy (Chemotherapy)
09/2003 - 12/2002
2Proton Therapy
01/2020 - 03/2015
2Molecular Targeted Therapy
06/2016 - 01/2011
2Immunotherapy
11/2007 - 01/2006
1Combined Modality Therapy
01/2020
1Nephrectomy
11/2018
1Biological Therapy
01/2018
1Brachytherapy
03/2015
1Duration of Therapy
01/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2008
1Lasers (Laser)
10/2005
1Cryotherapy (Therapy, Cold)
12/2002
1Neoadjuvant Therapy
12/2002